Press release
Global Molecular Diagnostics Market Set for Strong Growth Driven by Infectious Diseases and Technological Advances
The global molecular diagnostics market, valued at USD 19.86 billion in 2021, is projected to grow steadily with a revenue CAGR of 12.4% over the coming years. Rising cases of infectious diseases, growing adoption of point-of-care (PoC) tests, and technological innovations are fueling this growth. The increasing elderly population, which is more vulnerable to chronic and infectious diseases, is also driving demand for advanced diagnostic solutions.Request a Sample Report with Table of Contents and Figures to click Here: @ https://www.emergenresearch.com/request-sample/113
Key Market Drivers
One of the biggest growth factors for molecular diagnostics is rapid technological development. New techniques, such as Transcription-Mediated Amplification (TMA) and Loop-Mediated Isothermal Amplification (LAMP), are making diagnosis faster, more accurate, and cost-effective. Companies like QIAGEN and Sigma Aldrich are leading the way in developing these innovative methods.
The COVID-19 pandemic accelerated the adoption of molecular diagnostics. RT-PCR became the standard for detecting the virus, while PoC assays significantly reduced testing time. Beyond COVID-19, the rising burden of autoimmune diseases and cancers is further boosting the need for molecular testing.
Market Restraints
Despite strong growth, high costs of molecular diagnostic tools remain a challenge. Smaller hospitals, clinics, and laboratories often lack the budget to invest in expensive equipment, limiting wider adoption.
Product & Service Insights
Reagents & Kits: This segment held the largest market share in 2021 and is expected to grow the fastest. Demand is rising for quick and sensitive diagnostic kits, especially those used in infectious disease detection. Their cost-effectiveness and wide use in research and clinical settings are fueling adoption.
Instruments: Advanced devices that automate testing are seeing strong demand, particularly for COVID-19 detection and other infectious diseases.
Software & Services: Analyzer software, which automates diagnostic processes, is increasingly being adopted by diagnostic centers worldwide.
Technology Insights
Polymerase Chain Reaction (PCR): PCR dominated the market in 2021 due to its reliability in detecting microorganisms like viruses and bacteria. Multiplex PCR, which can test for multiple conditions at once, has become especially important.
DNA Sequencing & NGS: This segment is expected to grow at one of the highest rates, driven by its role in personalized medicine, drug discovery, and genome profiling. Costs of sequencing technologies are decreasing, making them more accessible.
In Situ Hybridization (ISH): ISH, including Fluorescence In Situ Hybridization (FISH), is gaining traction in cancer diagnosis and genetic research, especially as it works well with tissue samples commonly used in clinical labs.
Requesting A Customised Report @https://www.emergenresearch.com/request-for-customization/113
Application Insights
Infectious Diseases: This segment accounted for the largest share in 2021. Molecular diagnostics provide quick and reliable detection for diseases like COVID-19 and help healthcare systems respond faster to outbreaks.
Oncology: Expected to be the fastest-growing application segment, oncology is increasingly relying on molecular diagnostics for personalized treatment. Tests can identify mutations linked to cancers, guiding doctors in choosing the most effective therapies.
Other Applications: Neurological diseases, cardiovascular conditions, pharmacogenomics, and genetic testing are also growing areas where molecular diagnostics are playing a crucial role.
End-Use Insights
Hospitals & Clinics: This segment held the largest share in 2021 as molecular testing becomes more common in hospital labs, especially for infectious diseases and cancer care. Automated systems are helping hospitals deliver faster and more accurate results.
Diagnostic Centers: Expected to grow at the fastest rate, diagnostic centers are investing in advanced molecular testing equipment to meet rising demand for early disease detection.
Test Location Insights
Central Laboratories: These labs accounted for the largest share in 2021, supported by high testing volumes and government-funded diagnostic programs.
Point-of-Care (PoC): This segment is expected to grow the fastest. Portable and rapid PoC tests are increasingly being used in hospitals and clinics, as well as outside traditional healthcare settings. Companies like Alere, Roche Diagnostics, and Cepheid are already leading in this space.
To Read More About The Report, Visit @https://www.emergenresearch.com/industry-report/molecular-diagnostics-market
Molecular Diagnostics Market Top Companies and Competitive Landscape
The global molecular diagnostics market is fairly fragmented, with a number of large and medium-sized players accounting for majority of market revenue. Major players are deploying various strategies, entering into mergers & acquisitions, strategic agreements & contracts, developing, testing, and introducing more effective molecular diagnoses. Some major players included in the global molecular diagnostics market report are:
Abbott Laboratories
BioMérieux SA
BD (Becton, Dickinson and Company)
Siemens Healthcare GmbH
Danaher Corporation
Hoffmann-La Roche Ltd.
Thermo Fisher Scientific Corporation
QIAGEN
Quidel Corporation
Myriad Genetics, Inc.
Molecular Diagnostics Market Segmentation Analysis
For the purpose of this report, Emergen Research has segmented the global molecular diagnostics market based on product & service, technology, application, end-use, test location, and region:
Product & Service Outlook (Revenue, USD Billion; 2019-2030)
Reagent & Kits
Instruments
Software & Service
Technology Outlook (Revenue, USD Billion; 2019-2030)
Polymerase Chain Reaction (PCR)
Isothermal Nucleic Acid Amplification Technology (INAAT)
In Situ Hybridization (ISH)
DNA Sequencing & Next-Generation Sequencing
DNA Microarray
Transcription Mediated Amplification (TMA)
Others
Application Outlook (Revenue, USD Billion; 2019-2030)
Infectious Diseases
COVID-19
Hepatitis
Clostridium Difficile
Tuberculosis (TB) and Drug-resistant TB
HIV
Meningitis
Influenza
HPV
Respiratory Syncytial Virus (RSV)
Others
Oncology
Breast Cancer
Prostate Cancer
Cervical Cancer
Blood Cancer
Lung Cancer
Kidney Cancer
Others
Genetic Tests
Pharmacogenomics
Neurological Diseases
Cardiovascular Diseases
Microbiology
Others
End-use Outlook (Revenue, USD Billion; 2019-2030)
Hospital & Clinics
Diagnostics Centers
Others
Test Location Outlook (Revenue, USD Billion; 2019-2030)
Point-of-Care
Self-testing or Over the Counter
Central Laboratories
Regional Outlook (Revenue, USD Billion; 2019-2030)
North America
U.S.
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Benelux
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Rest of APAC
Latin America
Brazil
Rest of LATAM
Middle East & Africa
Saudi Arabia
UAE
South Africa
Turkey
Rest of Middle East & Africa
To Purchase Now, Click Here @https://www.emergenresearch.com/select-license/113
Read More Related Report
Biotechnology Market
https://www.emergenresearch.com/industry-report/biotechnology-market
Expanded Polystyrene Market
https://www.emergenresearch.com/industry-report/expanded-polystyrene-market
Peracetic Acid Market
https://www.emergenresearch.com/industry-report/peracetic-acid-market
Chemical Tankers Shipping Market
https://www.emergenresearch.com/industry-report/chemical-tankers-shipping-market
Butyl Rubber Market
https://www.emergenresearch.com/industry-report/butyl-rubber-market
Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Visit for More Insights: https://www.emergenresearch.com/insights
About Us:
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Molecular Diagnostics Market Set for Strong Growth Driven by Infectious Diseases and Technological Advances here
News-ID: 4148145 • Views: …
More Releases from Emergen Research

Global Internet of Things (IoT) in Healthcare Market to Reach USD 299.05 Billion …
The global Internet of Things (IoT) in Healthcare Market was valued at USD 299.05 billion in 2023 and is expected to grow at a CAGR of 16.5% during the forecast period. This growth is fueled by the rising use of connected healthcare devices, increasing demand for early disease detection through remote monitoring, and growing adoption of artificial intelligence (AI) tools within IoT-based healthcare systems.
The market is also benefiting from the…

Global Stem Cell Therapy Market to Reach USD 49.2 Billion by 2034, Growing at 13 …
The global Stem Cell Therapy Market, valued at USD 13.7 billion in 2024, is projected to reach USD 49.2 billion by 2034, expanding at a compound annual growth rate (CAGR) of 13.6%. Growth is being fueled by the rising burden of chronic diseases, rapid progress in cell-based studies, and increasing investments in regenerative medicine and personalized healthcare solutions.
Stem cell therapies offer the ability to repair, replace, or restore damaged tissues…

Artificial Intelligence Strengthens Cybersecurity as Threats Grow More Sophistic …
The global Artificial Intelligence in cybersecurity market size was USD 23.8 Billion in 2023 and is expected to reach a market valuation of USD 29.44 billion by the end of 2024 registering a CAGR of 23.7% during the forecast period. The adoption of Artificial Intelligence (AI) in cybersecurity is rapidly gaining traction as organizations worldwide face increasingly complex and frequent cyber threats. By combining advanced technologies such as Machine Learning…

Global Regenerative Medicine Market to Reach USD 125.6 Billion by 2034, Growing …
The global regenerative medicine market, valued at USD 34.2 billion in 2024, is set to grow to USD 125.6 billion by 2034, expanding at a compound annual growth rate (CAGR) of 13.9%. Growth is being fueled by rising approvals of advanced therapies, strong demand for personalized treatments in cancer and orthopedics, and expanding cell and gene therapy manufacturing across major markets such as North America, Europe, and Asia.
Once seen as…
More Releases for Diagnostic
Rubella Diagnostic Testing Market Report 2024 - Rubella Diagnostic Testing Marke …
"The Business Research Company recently released a comprehensive report on the Global Rubella Diagnostic Testing Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.
Ready to Dive into Something Exciting? Get Your Free Exclusive…
Diagnostic Electrocardiograph Market - Elevating Cardiac Care: Diagnostic Electr …
Newark, New Castle, USA: The "Diagnostic Electrocardiograph Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Diagnostic Electrocardiograph Market: https://www.growthplusreports.com/report/diagnostic-electrocardiograph-market/7804
This latest report researches the industry structure, sales, revenue,…
Diagnostic Imaging Market - Empowering Precision Medicine: Harnessing the Potent …
Newark, New Castle, USA: The "Diagnostic Imaging Market" provides a value chain analysis of revenue for the anticipated period from 2021 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Diagnostic Imaging Market: https://www.growthplusreports.com/report/diagnostic-imaging-market/7688
This latest report researches the industry structure, sales, revenue,…
Rubella Diagnostic Testing Market - Advancing Rubella Control: Innovating Diagno …
Newark, New Castle, USA - new report, titled Rubella Diagnostic Testing Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Rubella Diagnostic Testing market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Rubella Diagnostic Testing market. The report offers an overview of…
Tenet Diagnostic: Reshaping the Diagnostic Industry in India
Tenet Diagnostic was incorporated in 2018 with an aim to establish high-quality diagnostics laboratories across India. The company caters to both B2B and B2C. They have seven different verticals namely: End Customer (B2C), Lab to Lab Test Outsourcing, Corporates and Institutions, large management (Hospitals, Medical Colleges, and other healthcare institutions), Clinical Trials, Home Sample Collection, and Government PPP Projects.
Tenet Diagnostics got its NABL certification in the fastest time and is…
Diagnostic Imaging Services Market 2019 Analyzed by Top Key Players PH3 Healthca …
Big Market Research has added a report, titled, "Diagnostic Imaging Services" The report not only provides a comprehensive analysis of market overview and dynamics for the historical period, 2019-2026, but also offers global and regional forecasts on market value, volume production, and consumption during the future period, 2019-2026. The report also analyzes the key market players, especially the distributors, along with the industrial chain structure. The evolution of market trends…